EASTON BIOPHARMACEUTICALS: Pirfenidone tablets have obtained a drug registration certificate
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, EASTON BIOPHARMACEUTICALS announced that the company recently received the drug registration certificate for Pirfenidone Tablets approved and issued by the National Medical Products Administration (referred to as "NMPA"). The main active ingredient of Pirfenidone Tablets is Pirfenidone, which is classified as a Class II controlled substance under the National Regulations on the Administration of Narcotic Drugs and Psychotropic Substances. It is indicated for the treatment of partial seizures in adults and children aged 4 years and older (with or without secondary generalized seizures)
According to the Zhitong Finance APP, EASTON BIOPHARMACEUTICALS (688513.SH) announced that it recently received the drug registration certificate for Pirfenidone Tablets issued by the National Medical Products Administration (referred to as "NMPA").
The main active ingredient of Pirfenidone Tablets is Pirfenidone, which is classified as a Class II psychotropic drug according to the National Regulations on the Administration of Narcotic Drugs and Psychotropic Substances. It is indicated for the treatment of partial seizures in adults and children aged 4 years and older (with or without secondary generalized seizures)